Education
About Us
Working with TipRanks
Follow Us
MeVis Medical Solutions AG (DE:M3V)
XETRA:M3V
RESEARCH TOOLSreports
Total Valuation
MeVis Medical Solutions has a market cap or net worth of €45.14M. The enterprise value is €38.61M.
Market Cap€45.14M
Enterprise Value€38.61M
Share Statistics
MeVis Medical Solutions has 1,820,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,820,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
MeVis Medical Solutions’s return on equity (ROE) is 0.26 and return on invested capital (ROIC) is 19.44%.
Return on Equity (ROE)0.26
Return on Assets (ROA)0.17
Return on Invested Capital (ROIC)19.44%
Return on Capital Employed (ROCE)0.20
Revenue Per Employee169.72K
Profits Per Employee45.61K
Employee Count100
Asset Turnover0.64
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.
PE Ratio10.5
PS Ratio0.00
PB Ratio2.53
Price to Fair Value2.35
Price to FCF0.00
Price to Operating Cash Flow0.00
PEG Ratio2.16
Income Statement
In the last 12 months, MeVis Medical Solutions had revenue of 16.97M and earned 4.56M in profits. Earnings per share was 2.51.
Revenue16.97M
Gross Profit16.48M
Operating Income4.00M
Pretax Income4.69M
Net Income4.56M
EBITDA4.82M
Earnings Per Share (EPS)2.51
Cash Flow
In the last 12 months, operating cash flow was 96.63K and capital expenditures 0.00, giving a free cash flow of 96.63K billion.
Operating Cash Flow96.63K
Free Cash Flow96.63K
Free Cash Flow per Share0.05
Dividends & Yields
MeVis Medical Solutions pays an annual dividend of €0.95, resulting in a dividend yield of 3.83%
Dividend Per Share€0.95
Dividend Yield3.83%
Payout Ratio40.17%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.11
52-Week Price Change0.47%
50-Day Moving Average25.07
200-Day Moving Average24.58
Relative Strength Index (RSI)55.28
Average Volume (3m)41.00
Important Dates
MeVis Medical Solutions upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend DateMar 26, 2025
Financial Position
MeVis Medical Solutions as a current ratio of 1.50, with Debt / Equity ratio of 0.00%
Current Ratio1.50
Quick Ratio1.50
Debt to Market Cap0.00
Net Debt to EBITDA-1.35
Interest Coverage Ratio204.00
Taxes
In the past 12 months, MeVis Medical Solutions has paid 126.40K in taxes.
Income Tax126.40K
Effective Tax Rate0.03
Enterprise Valuation
MeVis Medical Solutions EV to EBITDA ratio is 7.33, with an EV/FCF ratio of 12.42.
EV to Sales2.08
EV to EBITDA7.33
EV to Free Cash Flow12.42
EV to Operating Cash Flow11.23
Balance Sheet
MeVis Medical Solutions has €4.87M in cash and marketable securities with €0.00 in debt, giving a net cash position of -€4.87M billion.
Cash & Marketable Securities€4.87M
Total Debt€0.00
Net Cash-€4.87M
Net Cash Per Share-€2.68
Tangible Book Value Per Share€9.79
Margins
Gross margin is 39.33%, with operating margin of 23.58%, and net profit margin of 26.87%.
Gross Margin39.33%
Operating Margin23.58%
Pretax Margin27.62%
Net Profit Margin26.87%
EBITDA Margin28.40%
EBIT Margin27.73%
Analyst Forecast
The average price target for MeVis Medical Solutions is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-2.14%
EPS Growth Forecast-7.29%